Skip to Main Content

Paper Details

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
21
2023
CV, CV death, DAPA, Dapagliflozin, HF, Heart Failure, Patients, SGLT2, Sodium, Sodium-glucose cotransporter-2, Women, all, atrial fibrillation, dapagliflozin, diabetes, glucose, heart failure, hypertension, men, myocardial infarction, patient, patients, stroke, women
Author NameAffiliation
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Mikhail KosiborodSaint Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.N.K.).
Rudolf A de BoerErasmus Medical Center
Marc S SabatineBrigham and Women's Hospital, Harvard Medical School
Marc S Sabatine
Marc S SabatineBrigham and Women's Hospital, Harvard Medical School
Marc S Sabatine
Adrian F HernandezDuke Clinical Research Institute, Duke University School of Medicine
Carolyn S P LamNational Heart Centre Singapore and Duke-National University of Singapore (C.S.P.L.).
  • 1 - 9

Datasets

Release 1.2